Rinvoq
NDC 0074-2320, Upadacitinib, solution, from AbbVie Inc..
- Product NDC
- 0074-2320
- Status
- Listed
- Labeler
- AbbVie Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218347
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0074-2320 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- UPADACITINIB1 mg/mL
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0074-2320-01 | 00074232001 | 1 BOTTLE in 1 CARTON (0074-2320-01) / 180 mL in 1 BOTTLE |
| 0074-2320-70 | 00074232070 | 1 BOTTLE in 1 CARTON (0074-2320-70) / 180 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2966aec7-2ef0-923c-d8ff-fe1a957bf095
Use it
Look up 0074-2320 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0074-2320 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0074-2320. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.